These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27441752)

  • 1. Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
    Lischalk JW; Kaplan ID; Collins SP
    Cancer J; 2016; 22(4):307-13. PubMed ID: 27441752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy for prostate cancer-a review.
    Haque W; Butler EB; Teh BS
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S10. PubMed ID: 28917248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer.
    Kishan AU; King CR
    Semin Radiat Oncol; 2017 Jul; 27(3):268-278. PubMed ID: 28577834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
    Kotecha R; Djemil T; Tendulkar RD; Reddy CA; Thousand RA; Vassil A; Stovsky M; Berglund RK; Klein EA; Stephans KL
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):960-964. PubMed ID: 27302511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer.
    Oermann EK; Slack RS; Hanscom HN; Lei S; Suy S; Park HU; Kim JS; Sherer BA; Collins BT; Satinsky AN; Harter KW; Batipps GP; Constantinople NL; Dejter SW; Maxted WC; Regan JB; Pahira JJ; McGeagh KG; Jha RC; Dawson NA; Dritschilo A; Lynch JH; Collins SP
    Technol Cancer Res Treat; 2010 Oct; 9(5):453-62. PubMed ID: 20815416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3)).
    Janowski E; Chen LN; Kim JS; Lei S; Suy S; Collins B; Lynch J; Dritschilo A; Collins S
    Radiat Oncol; 2014 Nov; 9():241. PubMed ID: 25398516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy for Patients with Early-stage Prostate Cancer.
    Linney H; Barrett S
    Anticancer Res; 2018 Mar; 38(3):1231-1240. PubMed ID: 29491045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
    Zilli T; Scorsetti M; Zwahlen D; Franzese C; Förster R; Giaj-Levra N; Koutsouvelis N; Bertaut A; Zimmermann M; D'Agostino GR; Alongi F; Guckenberger M; Miralbell R
    Radiat Oncol; 2018 Sep; 13(1):166. PubMed ID: 30180867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
    Fuller DB; Wurzer J; Shirazi R; Bridge SS; Law J; Mardirossian G
    Pract Radiat Oncol; 2015; 5(6):e615-23. PubMed ID: 26059509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer.
    King CR; Brooks JD; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):877-82. PubMed ID: 21300474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP; Nichols RC; Lei S; Wu B; Huh SN; Morris CG; Lee S; Tong M; Mendenhall NP; Dritschilo A; Collins SP
    Acta Oncol; 2015 Jun; 54(6):825-31. PubMed ID: 25227898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.
    Seymour ZA; Chang AJ; Zhang L; Kirby N; Descovich M; Roach M; Hsu IC; Gottschalk AR
    Pract Radiat Oncol; 2015; 5(5):e465-e472. PubMed ID: 25795252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
    Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD
    Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy as boost for organ-confined prostate cancer.
    Katz AJ; Santoro M; Ashley R; Diblasio F; Witten M
    Technol Cancer Res Treat; 2010 Dec; 9(6):575-82. PubMed ID: 21070079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Body Radiotherapy for Primary Prostate Cancer.
    Kothari G; Loblaw A; Tree AC; van As NJ; Moghanaki D; Lo SS; Ost P; Siva S
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789633. PubMed ID: 30064301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for prostate cancer: is the technology ready to be the standard of care?
    Zaorsky NG; Studenski MT; Dicker AP; Gomella L; Den RB
    Cancer Treat Rev; 2013 May; 39(3):212-8. PubMed ID: 23218442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review.
    Arcangeli S; Scorsetti M; Alongi F
    Crit Rev Oncol Hematol; 2012 Oct; 84(1):101-8. PubMed ID: 22257653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.
    Dess RT; Jackson WC; Suy S; Soni PD; Lee JY; Abugharib AE; Zumsteg ZS; Feng FY; Hamstra DA; Collins SP; Spratt DE
    Cancer; 2017 May; 123(9):1635-1642. PubMed ID: 28001303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.